128 related articles for article (PubMed ID: 3189442)
1. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
Rubin SC; Hoskins WJ; Hakes TB; Markman M; Cain JM; Lewis JL
Am J Obstet Gynecol; 1988 Nov; 159(5):1094-8. PubMed ID: 3189442
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Rubin SC; Hoskins WJ; Saigo PE; Chapman D; Hakes TB; Markman M; Reichman B; Almadrones L; Lewis JL
Gynecol Oncol; 1991 Aug; 42(2):137-41. PubMed ID: 1894172
[TBL] [Abstract][Full Text] [Related]
3. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.
Rubin SC; Randall TC; Armstrong KA; Chi DS; Hoskins WJ
Obstet Gynecol; 1999 Jan; 93(1):21-4. PubMed ID: 9916949
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
6. A review of second-look laparotomy for ovarian cancer.
Cain JM; Saigo PE; Pierce VK; Clark DG; Jones WB; Smith DH; Hakes TB; Ochoa M; Lewis JL
Gynecol Oncol; 1986 Jan; 23(1):14-25. PubMed ID: 3943748
[TBL] [Abstract][Full Text] [Related]
7. [Follow-up of 70 patients with advanced ovarian cancer after negative second-look laparotomy].
Kojs Z; Glinski B; Pudelek J; Urbanski K; Karolewski K; Mitus J; Reinfuss M
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1):16-22. PubMed ID: 16446607
[TBL] [Abstract][Full Text] [Related]
8. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
10. Microscopic disease at second-look laparotomy in advanced ovarian cancer.
Copeland LJ; Gershenson DM; Wharton JT; Atkinson EN; Sneige N; Edwards CL; Rutledge FN
Cancer; 1985 Jan; 55(2):472-8. PubMed ID: 3965102
[TBL] [Abstract][Full Text] [Related]
11. Consolidative 32P after second-look laparotomy for ovarian carcinoma.
Condra KS; Mendenhall WM; Morgan LS; Marcus RB
Radiat Oncol Investig; 1998; 6(2):97-102. PubMed ID: 9572686
[TBL] [Abstract][Full Text] [Related]
12. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
13. [Patients with advanced ovarian cancer after negative second-look laparoscopy--follow up study].
Pudełek J; Kojs Z; Urbański K; Mituś J; Reinfuss M; Klimek M
Ginekol Pol; 2004 Feb; 75(2):85-90. PubMed ID: 15108578
[TBL] [Abstract][Full Text] [Related]
14. [Tumor recurrence following negative second-look laparotomy in ovarian carcinoma].
Schneider J; Barbazan M; Centeno M; Montoya F; Neyro JL; Rodriguez-Escudero FJ
Zentralbl Gynakol; 1991; 113(22):1246-50. PubMed ID: 1755261
[TBL] [Abstract][Full Text] [Related]
15. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
16. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
17. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
[TBL] [Abstract][Full Text] [Related]
19. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
[TBL] [Abstract][Full Text] [Related]
20. Second-look laparotomy and salvage therapy: a research modality only?
Potter ME; Hatch KD; Soong SJ; Partridge EE; Austin JM; Shingleton HM
Gynecol Oncol; 1992 Jan; 44(1):3-9. PubMed ID: 1303613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]